Introduction
The use of plants for healing purposes is becoming increasingly popular, as they are believed to be beneficial and free from side effects. However, most of the information available on many medicinal herbs has no supporting scientific data and their use as medicaments is based solely on traditional folk usage that has been perpetuated down through the generations (1) .
Miconia is a genus including $1000 species occurring in tropical America (2, 3) . The genus belongs to the Melastomataceae family, which is pantropical with .166 genera that include $4300 species (2) . Many of these plants are used as medicine by people living in the Cerrado area, a Brazilian savannah ecosystem.
Studies aiming to describe the diverse biological activities of the Miconia species have shown promising results. Some studies have described the analgesic effects of crude extracts (hexane, methylene chloride and ethanol) obtained from Miconia species (4) (5) (6) . Triterpenes ursolic acid, oleanolic acid and gypsogenic acid of Miconia fallax DC. and Miconia stenostachya (Schrank & Mart.) DC. were active against blood trypomastigote forms of Trypanosoma cruzi (7) . Phenolic compounds from Miconia myriantha Benth showed inhibitory effects against aspartic proteases secreted by Candida albicans (8) . Primin, an antibiotic extracted from Miconia sp. (Herb. I.A.-1903) with a 2-metoxi-6-n-pentil-p-benzoquinone structure, presented strong anti-neoplastic action in cases of patients presenting basal cell carcinoma and in one case of a patient presenting Kaposi's sarcoma (9) .
Although numerous biological activities of the Miconia species have been reported, no studies concerning their effects on DNA (induction, reduction or mutation prevention) are currently available for the species. Mutations in somatic cells are important in the evolutionary process, but are also involved in the mechanisms of carcinogenesis and have a relevant role in degenerative chronic diseases, such as arteriosclerosis and heart diseases, which are the main causes of death in the human population (10) .
Since most cancers are likely to be associated with mutagens and/or mitogens, research focusing on compounds that may inhibit or reverse either of the related processes may be crucial in the search for chemotherapeutic agents (11) . Epidemiological studies have suggested that a reduced risk of cancer is associated with high consumption of vegetables and fruit. Thus, the cancer chemopreventive potential of naturally occurring phytochemicals is of great interest (12) . Antimutagenic activity has been described for compounds isolated from plants, such as phenolic acids (ferulic and gentisic acids) (13), tannins and flavonoids (14) (15) (16) and terpenes (17) .
The aim of the present study was to evaluate the genotoxic and mutagenic potential of extracts from four Miconia species in vivo, using the comet assay and the micronucleus test, as well as the possible protective effects of these extracts against cyclophosphamide (CPA)-induced DNA damage.
Animals
Male and female albino Swiss mice (Mus musculus), aged 7-8 weeks old and weighing $30 g at the beginning of the experiments, were used for the comet assay and micronucleus test. They were obtained from the mouse-breeding colony at the State University of Londrina (Paraná, Brazil) and were kept individually in polypropylene cages following the conditions for animal care recommended by the Canadian Council on Animal Care (18) .
The mice (n 5 250) were divided into groups of 10 (five males and five females) for each treatment and these (animals) mice were the same for both the end points (comet assay and micronucleus test). 
Plant material and extract preparation

Experimental design
The mice were treated with 0.1 ml of each of the solutions for every 10 g of body weight (bw) and they received water and food ad libitum throughout the treatment period. To evaluate the genotoxicity and mutagenicity of the extracts, the extracts were assessed at three different doses: 200, 400 and 540 mg/kg bw, via gavage. These doses were based on the solubility limit of the methanolic extract of M. albicans in distilled water. Thus, only one dose was tested for all the extracts and the results obtained for all the extracts at the same dose were compared. Given the low solubility of the CHCl 3 extract, it had to be diluted in 8% Tween, since a dose of 540 mg/kg bw was unobtainable in distilled water.
A negative control group, positive control group and solvent control group were established for the treatment of the mice with distilled water, CPA [40 mg/ kg bw intraperitoneally (i.p.)] and 8% Tween, respectively. To assess the antimutagenic activity of four Miconia species, CPA was administrated in a single i.p. dose 1 h after the plant extract was administered via gavage. Only the highest dose, 540 mg/kg bw, of each extract was evaluated regarding its protective effects.
Comet assay
The alkaline version of the comet assay was performed according to the guidelines proposed by Singh et al. (19) , with a slight modification (20) . Twenty-four hours after the treatment, 20 ll of heparinized periphery blood was mixed with 120 ll of 0.5% low-melting-temperature agarose in phosphatebuffered saline (PBS) and applied to microscope slides pre-coated with 1.5% normal-melting-temperature agarose in PBS. The slides were covered with a microscope coverslip and refrigerated for 5 min to gel. This was followed by immersion in ice-cold alkaline lysing solution [2.5 M NaCl, 10 mM Tris, 100 mM ethylenediaminetetraacetic acid (EDTA), 10% dimethyl sulphoxide, 1% Triton X-100, final pH 10.0] for at least 1 h. The slides were then incubated for 20 min in ice-cold electrophoresis solution (0.3 M NaOH, 1 mM EDTA, pH . 13), followed by electrophoresis at 25 V:300 mA (1.25 V/cm) for 25 min (21) . After electrophoresis, the slides were then neutralized (Tris 0.4 M, pH 7.5) and stained with ethidium bromide (20 lg/ml). One hundred cells per mouse (50 cells analysed in each slide) were scored at 400Â using a fluorescence microscope (Nikon-Brazil) with a blue (488 nm) excitation filter and yellow (515 nm) emission (barrier) filter. One scorer analysed the slides throughout the study and all the slides were coded. Quantification of DNA breakage was realized by visual scoring and the cells were classified into four categories representing different degrees of DNA damage, ranging from no visible migration (class 0, undamaged cells) to the maximum length comet [class 3, maximally damaged cells (DC)] (22) .
The frequency of DC was obtained by totalling the number of undamaged (class 0) and DC from classes 1, 2 and 3 and dividing by the total number of cells analysed in each treatment. The total score for 100 nucleoids was obtained by multiplying the number of cells in each class by the damage class, according to the formula modified from Manoharan and Banerjee (23) . Total score
, where n 5 number of cells in each class analysed. Thus, the total score could range from 0 (100 cells presenting no damage) to 300 (all cells presenting damage class 3).
The percentage reduction in the comet assay for the treatments with extracts showing anti-genotoxicity was calculated according to Manoharan and Banerjee (23) where A is the group of cells treated with CPA (positive control); B is the group of cells treated with the extracts plus CPA and C is the negative control. The data were not homogeneous with regard to variance, so the KruskalWallis test followed by Dunn's post hoc test was used to analyse the results.
Micronucleus test
The micronucleus test was performed on peripheral blood cells from the tail vein according to the protocol described by Hayashi et al. (25) , which uses slides pre-stained with acridine orange (CAS: 494-38-2). The glass slides were heated to $70°C on a hot plate and a 10-ll drop of an aqueous solution of the dye (1 mg/ml) was placed on each slide and spread evenly over the surface with the end of a second well-cleaned slide. Once dry, the slides were kept in the dark at room temperature for at least 24 h.
An internal control was established for each mouse by preparing a test slide with a drop of blood taken from its tail before the first treatment (time T 0 ). Thirty hours after the treatment with the different compounds (T 1 ), blood was obtained by perforating the caudal vein of the mouse with a needle and collecting 5 ll drops, each of which was placed at the centre of a pre-stained slide and covered with a coverslip (24 Â 50 mm). These slides were then kept in the dark at À20°C for a minimum of 24 h before the cytological examination of the blood cells was performed.
The cell preparations were examined under a fluorescence microscope (Nikon) with a blue (488 nm) excitation filter and yellow (515 nm) emission (barrier) filter, using an immersion objective. One thousand reticulocytes per treated mouse were analysed and the proportion of micronucleated cells was counted.
The mean frequencies of micronucleated cells obtained for times T 0 and T 1 in each treatment group were compared by the Student t test (P , 0.05). The statistical ANOVA-Tukey test was used to calculate the means and standard deviations in order to compare the results obtained for the groups treated with extracts and the negative control group. The percentage reduction in the frequencies of micronucleated cells from the treatments with extracts that showed anti-mutagenicity was calculated according to Manoharan and Banerjee (23) and Waters et al. (24) as described above.
Results
The results of genotoxicity, mutagenicity and protective effects obtained for males and females were grouped to constitute Tables I, II, III and IV; no statistical difference occurred among the results obtained for these groups, demonstrating that gender differences do not modify the activity of the plant extract in these mice. Table I shows the results of the comet assay for all three doses (200, 400 and 540 mg/kg bw) of each of the five plant extracts. The average values of the scores and frequency of DC obtained for all the doses and extracts evaluated were statistically different from the negative control (P , 0.001), indicating genotoxic activity.
Negative results for the micronucleus test were observed for all treatment groups (Table II) , while statistically significant differences between T 0 and T 1 (Student t test) were detected only for the positive control group (CPA). After 30 h of treatment (T 1 ), the data of all the experimental groups were compared with each other using the ANOVA and Tukey tests. Only the positive control group differed from the remaining groups (P , 0.001).
All extracts presented protective activity, since the results were statistically different from those obtained from the positive control group. Analysis of the values obtained for In vivo assessment of DNA damage the extracts revealed a reduction in the scores and frequency of DC in relation to the group treated with CPA (P , 0.001) (Table III) , as well as a reduction in the frequency of micronucleated cells (Table IV) 
Discussion
In order to develop unknown products and chemicals, it is necessary to determine their potential mutagenic effects. A balance between the therapeutic versus toxicological effects of a compound is important when verifying its applicability as a pharmacological drug (26) .
All of the Miconia extracts evaluated presented low levels of genotoxicity according to the comet classes detected, with a predominance of comet class 1. The values obtained for cells treated with extracts were mid-range between those obtained in the negative control group and the group treated with the known mutagen CPA. This fact suggests moderate genotoxicity for these extracts. In the comet assay, it was possible to quantify and to distinguish cells with different rates of DNA damage, thus the analysis of the average values of the scores Table III . Detection of DNA damage using the comet assay of 100 white blood cells per mouse (n 5 10 mice per group) exposed to water, 8% Tween, CPA and vegetal extracts of Miconia species associated with CPA and sampled at 24 h (mean AE SD) for each group was very important. In the present work, a predominance of comet class 1 was observed for all the treatment groups and almost no predominance for comet classes 2 and 3, differing from the data obtained for CPA, where comet classes 1 and 2 predominated. Anomalies in the DNA molecule, such as adducts and singleand double-strand breaks, might cause lesions that become permanent and the use of the micronucleus test is an excellent means of evaluating any permanent damage in the genetic material. The same extracts used in the present study were evaluated by our group concerning their potential cytotoxicity (clonogenic assay) and mutagenicity (micronucleus test) in V 79 cell line in vitro and three non-cytotoxic concentrations, chosen through clonogenic assay (5, 10 and 20 lg/ml), showed absence of mutagenicity (Serpeloni et al., unpublished data).
The frequency of micronucleated cells was evaluated 30 h after the treatment. This time was chosen according to the literature data (27, 28) , which describe kinetics of micronucleus formation and cell migration. Both studies showed an elevation in the frequency of micronucleated cells even at 24 h and the peak of these cells in the peripheral blood is $36 h after treatment. In the present study, no increase was observed 30 h after the treatment and all experimental groups showed the same frequency of micronucleated cells obtained in the negative control, which permitted the conclusion that the extracts were not mutagenic. Therefore, the negative results for mutagenicity observed in vivo in the present study may indicate that (i) the primary lesions (strand breaks) in the comet assay were repaired and this prevented the observation of micronuclei; (ii) the lesions induced in the comet assay were mainly single-strand breaks, which are less effective at producing chromosome fragments than double-strand breaks (29) and (iii) the prevalent DNA lesions leading to effects in the comet assay may have been DNA modifications, such as abasic sites involved predominantly in the induction of gene mutations (30) rather than in micronucleus induction.
The combination of these two assays in the present work proved to be both adequate and useful in the evaluation of the genotoxicity of the extracts from Miconia species, due to their complementary action.
CPA is an alkylating agent, which after administration is widely distributed throughout the body with a low degree of plasma protein binding (20%). Once activated, besides causing monoadducts, it can induce the formation of DNA-DNA and DNA-protein cross links (31) and generate free radicals that cause reactive species in a secondary mechanism leading to DNA damage (32) . Consequently, CPA has been used as a clastogenic agent to induce cellular damage in the micronucleus test for evaluating mutagenic and anti-mutagenic activities (33) .
In the present study, the protective effects of the Miconia extracts against CPA-induced DNA damage were observed via the comet assay and in the micronucleus assay. These effects can be explained as the result of the chemical constituents present in the extracts. A partial chemical analysis of the methanolic extract of M. cabucu showed that polyphenols (flavonoids, tannins and phenolic compounds) are the main compounds of this extract (34) . Fractionation of the methanolic extract from M. cabucu was performed by Rodrigues et al. According to Scalbert and Williamson (35) , most of the polyphenols ingested (75-99%) are not found in the urine and bioavailability studies have shown that maximum flavonoids concentrations are most often reached 1-2 h after ingestion, except for polyphenols, which are absorbed only after partial degradation by the colon microflora. According Anderson et al. (33) , peak CPA concentrations in the blood plasma occur $1 h after administration. Considering that the metabolism of CPA is faster than that of the extract components and the ample absorption of the same, the 1-h interval between the administration of the extracts and CPA injection aimed to place the CPA and extract metabolites in contact at the same time in the blood plasma.
A wide variety of botanical material, mostly dietary flavonoids and phenolic substances, have been reported to present expressive anti-carcinogenic and anti-mutagenic activities due to their antioxidant and anti-inflammatory properties (36) . As antioxidants, flavonoids are capable of inhibiting the formation of free radicals and also of eliminating them by donating hydrogen atoms to these molecules and interrupting the chain reaction (37) .
Phenolic compounds are found naturally in various agricultural products, such as coffee beans, fruits, vegetables, tobacco leaves, olive oils and wines (38) . Caffeic acid, a well-studied phenolic compound, exhibits a cytoprotective effect on endothelial cells against oxidized low-density lipoprotein In vivo assessment of DNA damage (39) . It also inhibits the oxidation of lipoprotein exposed to ferrylmyoglobin and recycles a-tocopherol from a-tocopherol radicals (40) . Similar to other phenolic acids (ferulic and gentisic acids), caffeic acid exhibited a protective effect against the genotoxicity of acridine orange and ofloxacin in Salmonella typhimurium (13) .
Tannins are one such class of compounds that are suspected of possessing protective properties (14) . Fedeli et al. (41) showed that tannins are capable of protecting against DNA breakage at low concentrations, while at high concentrations they could be genotoxic. Chen and Chung (42) showed the protective effect of tannins against mutagenicity induced by agents, which, like CPA, show indirect mutagenicity: benzidine, 4-aminobi-phenyl, 3,3#-4,4#-tetraaminobiphenyl and N,N-N#,N#-tetramethylbenzidine. Several authors also have shown that ellagic acid, tannin detected in the chemical analyses of Miconia extracts, presents protective effects for different types of cells treated with different mutagenic agents (43, 44) .
The additive and synergistic effects of phytochemicals in fruit and vegetables have also been proposed as responsible for their potent antioxidant and anti-cancer activities (45) . Among the distinguished compounds detected in the Miconia extracts are tannins, phenolic acids and flavonoids, which have been described as anti-mutagenic agents when assessed separately. Their interactions and possible synergistic effects may facilitate the protective effects observed.
The present study showed that the use of crude extracts can be more advantageous than the use of isolated compounds. The interaction between phytochemicals in the extracts showed efficacy in reducing mutagenicity and improving the protective effects.
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